Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa

  • STATUS
    Recruiting
  • days left to enroll
    6
  • participants needed
    50
  • sponsor
    Beirut Eye Specialist Hospital
Updated on 21 January 2021
levodopa

Summary

The purpose of this study is to evaluate the effect of L-Dopa on the progression of retinitis pigmentosa.

Description

Retinitis pigmentosa is a group of progressive hereditary diseases that diffusely affects the functioning of photoreceptors and the pigment epithelium. It may be speculated that a protective effect on the pigment epithelium, as it is supposed for L-Dopa, can slow the progression of the disease or even lead to an, at least transient, improvement of visual functions. To evaluate the effect of L-Dopa on retinitis pigmentosa progression, visual acuity, electroretinogram and visual field will be preformed regularly.

Details
Condition Retinitis Pigmentosa
Treatment levodopa-carbidopa
Clinical Study IdentifierNCT02837640
SponsorBeirut Eye Specialist Hospital
Last Modified on21 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

All confirmed cases of retinitis pigmentosa
VA of 20/400 or better

Exclusion Criteria

Advanced stages of retinitis pigmentosa with poor best corrected visual acuity (less than 20/400)
co-existing eye morbidities interfering with retinitis pigmentosa (glaucoma, retinal detachment...)
Flat electroretinogram
Intolerance or counterindication to drug
Unability for long-term follow-up
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note